Novo Nordisk will discontinue its long-acting insulin treatment Levemir in the U.S. by the end of next year, the company announced Wednesday.
Tag Archive for: Levemir
Novo will reduce the list price of its NovoLog insulin by 75%, and for Novolin and Levemir by 65%.
Supply problems with the weight loss drug Wegovy were a stumbling block to growth, but Novo Nordisk has rallied.
